These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19383493)

  • 1. Profile of the new pyrrolidone derivative seletracetam (ucb 44212) in animal models of epilepsy.
    Matagne A; Margineanu DG; Potschka H; Löscher W; Michel P; Kenda B; Klitgaard H
    Eur J Pharmacol; 2009 Jul; 614(1-3):30-7. PubMed ID: 19383493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.
    Matagne A; Margineanu DG; Kenda B; Michel P; Klitgaard H
    Br J Pharmacol; 2008 Aug; 154(8):1662-71. PubMed ID: 18500360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
    Klitgaard H
    Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats.
    Kitano Y; Komiyama C; Makino M; Kasai Y; Takasuna K; Kinoshita M; Yamazaki O; Takazawa A; Yamauchi T; Sakurada S
    Epilepsia; 2005 Oct; 46(10):1561-8. PubMed ID: 16190926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy.
    Kaminski RM; Matagne A; Leclercq K; Gillard M; Michel P; Kenda B; Talaga P; Klitgaard H
    Neuropharmacology; 2008 Mar; 54(4):715-20. PubMed ID: 18207204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy.
    Pollard JR
    Curr Opin Investig Drugs; 2008 Jan; 9(1):101-7. PubMed ID: 18183537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seletracetam (UCB 44212).
    Bennett B; Matagne A; Michel P; Leonard M; Cornet M; Meeus MA; Toublanc N
    Neurotherapeutics; 2007 Jan; 4(1):117-22. PubMed ID: 17199025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam.
    Kaminski RM; Gillard M; Leclercq K; Hanon E; Lorent G; Dassesse D; Matagne A; Klitgaard H
    Epilepsia; 2009 Jul; 50(7):1729-40. PubMed ID: 19486357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
    Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S
    Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models.
    Leclercq K; Matagne A; Provins L; Klitgaard H; Kaminski RM
    J Pharmacol Exp Ther; 2020 Jan; 372(1):11-20. PubMed ID: 31619464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anticonvulsant effects of progesterone and its metabolites on amygdala-kindled seizures in male rats.
    Lonsdale D; Nylen K; McIntyre Burnham W
    Brain Res; 2006 Jul; 1101(1):110-6. PubMed ID: 16784731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical profiling and safety studies of ABT-769: a compound with potential for broad-spectrum antiepileptic activity.
    Giardina WJ; Dart MJ; Harris RR; Bitner RS; Radek RJ; Fox GB; Chemburkar SR; Marsh KC; Waring JF; Hui JY; Chen J; Curzon P; Grayson GK; Komater VA; Ku Y; Lockwood M; Miner HM; Nikkel AL; Pan JB; Pu YM; Wang L; Bennani Y; Durmuller N; Jolly R; Roux S; Sullivan JP; Decker MW
    Epilepsia; 2005 Sep; 46(9):1349-61. PubMed ID: 16146429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity profile of pregabalin in rodent models of epilepsy and ataxia.
    Vartanian MG; Radulovic LL; Kinsora JJ; Serpa KA; Vergnes M; Bertram E; Taylor CP
    Epilepsy Res; 2006 Mar; 68(3):189-205. PubMed ID: 16337109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of generalized absence seizures on the progression of kindling in the rat.
    Onat FY; Aker RG; Gurbanova AA; Ateş N; van Luijtelaar G
    Epilepsia; 2007; 48 Suppl 5():150-6. PubMed ID: 17910595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of cation-chloride co-transport-blocking diuretics in a rat hippocampal slice model of epilepsy.
    Margineanu DG; Klitgaard H
    Epilepsy Res; 2006 May; 69(2):93-9. PubMed ID: 16495037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromodulation with levetiracetam and vagus nerve stimulation in experimental animal models of epilepsy.
    Dedeurwaerdere S; Vonck K; De Herdt V; Waterschoot L; De Smedt T; Raedt R; Wyckhuys T; Legros B; Van Hese P; Van Laere K; Delbeke J; Wadman W; Boon P
    Acta Neurol Belg; 2006 Jun; 106(2):91-7. PubMed ID: 16898260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The delta-sleep inducing peptide and its effect on the electroencephalogram and power spectrum density in rats with metaphit-induced epilepsy].
    Stanojlovic O; Zivanovic D; Susic V
    Srp Arh Celok Lek; 2001; 129(5-6):114-8. PubMed ID: 11797457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seletracetam enhances short term depression in vitro.
    Yang X; Meehan AL; Rothman SM; Dubinsky JM
    Epilepsy Res; 2015 Nov; 117():17-22. PubMed ID: 26320080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GDNF released from encapsulated cells suppresses seizure activity in the epileptic hippocampus.
    Kanter-Schlifke I; Fjord-Larsen L; Kusk P; Angehagen M; Wahlberg L; Kokaia M
    Exp Neurol; 2009 Apr; 216(2):413-9. PubMed ID: 19162016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.